AIM ImmunoTech, Inc. (AIM)
1.13
-0.13
(-10.32%)
USD |
NYAM |
Dec 31, 16:00
1.07
-0.06
(-5.31%)
After-Hours: 05:32
AIM ImmunoTech Research and Development Expense (Annual): 6.149M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 79.05M |
| Perspective Therapeutics, Inc. | 39.33M |
| Protalix Biotherapeutics, Inc. | 12.97M |
| Electromed, Inc. | 0.996M |
| Armata Pharmaceuticals, Inc. | 34.43M |